𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anxious personality predicts an increased risk of Parkinson's disease

✍ Scribed by James H. Bower; Brandon R. Grossardt; Demetrius M. Maraganore; J. Eric Ahlskog; Robert C. Colligan; Yonas E. Geda; Terry M. Therneau; Walter A. Rocca


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
215 KB
Volume
25
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

We studied the association of three personality traits related to neuroticism with the subsequent risk of Parkinson's disease (PD) using a historical cohort study. We included 7,216 subjects who resided within the 120‐mile radius centered in Rochester, MN, at the time they completed the Minnesota Multiphasic Personality Inventory (MMPI) for research at the Mayo Clinic from 1962 to 1965. We considered three MMPI personality scales (pessimistic, anxious, and depressive traits). A total of 6,822 subjects (94.5%) were followed over four decades either actively or passively. During follow‐up, 227 subjects developed parkinsonism (156 developed PD). An anxious personality was associated with an increased risk of PD [hazard ratio (HR), 1.63; 95% confidence interval (CI), 1.16–2.27]. A pessimistic personality trait was also associated with an increased risk of PD but only in men (HR = 1.92; 95% CI = 1.20–3.07). By contrast, a depressive trait was not associated with increased risk. Analyses combining scores from the three personality scales into a composite neuroticism score showed an association of neuroticism with PD (HR = 1.54; 95% CI = 1.10–2.16). The association with neuroticism remained significant even when the MMPI was administered early in life (ages 20–39 years). By contrast, none of the three personality traits was associated with the risk of non‐PD types of parkinsonism grouped together. Our long‐term historical cohort study suggests that an anxious personality trait may predict an increased risk of PD developing many years later. Β© 2010 Movement Disorder Society.


πŸ“œ SIMILAR VOLUMES


Antibiotic use predicts an increased ris
✍ Annamari Kilkkinen; Harri Rissanen; Timo Klaukka; Eero Pukkala; Markku HeliΓΆvaar πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 76 KB πŸ‘ 1 views

## Abstract Antibiotic use has been hypothesized to be associated with the risk of cancer but the evidence is sparse and inconsistent. The aim of the present study was to determine whether antibiotic use predicts the development of various cancers. This nationwide cohort study included 3,112,624 in

No increased risk of obstructive sleep a
✍ Lynn Marie Trotti; Donald L. Bliwise πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 459 KB πŸ‘ 1 views

## Abstract Pulmonary function abnormalities in Parkinson's disease (PD) might predispose patients to obstructive sleep apnea (OSA) and daytime sleepiness. Fifty‐five idiopathic PD patients (mean age = 63.9) underwent three consecutive nights of in‐laboratory polysomnography on their usual dopamine

Do risk factors for Alzheimer's disease
✍ Gilberto Levy; Ming-Xin Tang; Lucien J. Cote; Elan D. Louis; Brenda Alfaro; Hele πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 1 views

## Abstract The extent to which concomitant Alzheimer's disease (AD) is etiologically related to the development of dementia in Parkinson's disease (PD) remains controversial. We explored the association of four risk factors associated with AD, including head injury, smoking, hypertension, and diab

LRRK2 G2019S mutations are associated wi
✍ Rachel Saunders-Pullman; Matthew J. Barrett; Kaili M. Stanley; Marta San Luciano πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 70 KB

## Abstract Leucine rich repeat kinase (__LRRK2__) G2019S mutations are presumed to cause PD through a toxic gain of function of the protein kinase. Small molecule kinase inhibitors have been developed for the treatment of certain cancers, and some antioncogenic agents such as sunitinib, may nonspe